NCT03030222 - Empagliflozin Impact on Hemodynamics in Patients With Heart Failure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 5, 2017

Primary Completion Date

March 10, 2020

Study Completion Date

March 10, 2020

Conditions

Heart Failure

Interventions

DRUG

Empagliflozin 10 mg Tab

DRUG

Placebo Oral Tablet

Empagliflozin matching placebo

Trial Locations (10)

St. Francis Hospital, Roslyn

Sentara Cardiovascular Research Institute, Norfolk

First Coast Cardiovascular Institute, Jacksonville

Ohio State University, Columbus

CentraCare Heart and Vascular Center, Saint Cloud

Sanford Research, Sioux Falls

NorthShore University Health System Research Institute, Evanston

Baylor College of Medicine, Houston

Austin Heart Clinical Research, Austin

University of Southern California, Los Angeles

All Listed Sponsors

lead

Saint Luke's Health System

OTHER